甲状腺超声影像组学研究预测甲状腺乳头状癌BRAF突变:初步结果
该研究回顾性纳入2012年1月至2013年6月手术确诊的96个甲状腺乳头状癌结节(BRAF突变阳性48个、阴性48个),从纵向和横向超声图像手动勾画ROI并提取86个影像组学特征,构建逻辑回归、支持向量机和随机森林三种分类模型(5折交叉验证)。结果显示三种模型平均AUC为0.651、准确率64.3%、敏感度66.8%、特异度61.8%,作者结论认为甲状腺超声影像组学在预测BRAF突变状态方面作用有限,需进一步研究验证。
要点
- 超声诊断的高可疑结节在BRAF突变阳性组中比例高于突变阴性组(P = .004)。
- 影像组学三种分类模型预测BRAF突变的平均AUC为0.651,判别能力中等。
- 作者结论认为甲状腺超声影像组学预测BRAF突变状态的作用有限。
核心结论
- 作者结论认为,使用甲状腺超声的影像组学研究在预测甲状腺乳头状癌BRAF突变状态方面作用有限。
- 作者指出,需要进一步研究采用多种诊断方法验证该结果。
研究设计与样本
- 回顾性研究,纳入2012年1月至2013年6月手术确诊的96个甲状腺乳头状癌结节,BRAF突变阳性48个、阴性48个。
- 在纵向和横向超声图像上手动勾画结节ROI,提取86个影像组学特征(直方图参数、灰度共生矩阵、强度大小区域矩阵和形状特征)。
- 采用5折交叉验证构建逻辑回归、支持向量机和随机森林三种分类模型,评估准确率、敏感度、特异度、阳性预测值、阴性预测值和AUC。
关键影像表现/征象
- 超声诊断为高可疑结节的出现在BRAF突变阳性组中多于突变阴性组(P = .004)。
诊断标准与关键数值
- 三种模型平均预测BRAF突变的AUC为0.651、准确率64.3%、敏感度66.8%、特异度61.8%。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文结论指出需要进一步研究采用多种诊断方法验证该结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: It is not known how radiomics using ultrasound images contribute to the detection of BRAF mutation. This study aimed to evaluate whether a radiomics study of gray-scale ultrasound can predict the presence or absence of B-Raf proto-oncogene, serine/threonine kinase (BRAF) mutation in papillary thyroid cancer.
MATERIALS AND METHODS: The study retrospectively included 96 thyroid nodules that were surgically confirmed papillary thyroid cancers between January 2012 and June 2013. BRAF mutation was positive in 48 nodules and negative in 48 nodules. For analysis, ROIs from the nodules were demarcated manually on both longitudinal and transverse sonographic images. We extracted a total of 86 radiomics features derived from histogram parameters, gray-level co-occurrence matrix, intensity size zone matrix, and shape features. These features were used to build 3 different classifier models, including logistic regression, support vector machine, and random forest using 5-fold cross-validation. The performance including accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and area under the receiver operating characteristic curve, of the different models was evaluated.
RESULTS: The incidence of high-suspicion nodules diagnosed on ultrasound was higher in the BRAF mutation-positive group than in the mutation-negative group (P = .004). The radiomics approach demonstrated that all classification models showed moderate performance for predicting the presence of BRAF mutation in papillary thyroid cancers with an area under the curve value of 0.651, accuracy of 64.3%, sensitivity of 66.8%, and specificity of 61.8%, on average, for the 3 models.
CONCLUSIONS: Radiomics study using thyroid sonography is limited in predicting the BRAF mutation status of papillary thyroid carcinoma. Further studies will be needed to validate our results using various diagnostic methods.
引用
- Kwon MR, Shin JH, Park H, et al. Radiomics Study of Thyroid Ultrasound for Predicting BRAF Mutation in Papillary Thyroid Carcinoma: Preliminary Results. AJNR Am J Neuroradiol. 2020. PMID: 32273326. doi:10.3174/ajnr.A6505
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。